Modi's 'self-reliance' call need of the hour: Pharma industry

Image
Press Trust of India New Delhi
Last Updated : May 13 2020 | 4:25 PM IST

The Indian pharma industry on Wednesday hailed Prime Minister Narendra Modi emphasising on making India self-reliant and said his speech captured the need of the moment in these trying times.

"The Prime Minister's speech captured the needof the hourperfectly.IPA lauds PM's vision on 'Vasudhaiva Kutumbakam' and self-reliance,"Indian Pharmaceutical Alliance (IPA)Secretary General Sudarshan Jain said in a statement.

During these unprecedentedtimes, the pharmaceutical industry has worked with the government in an integrated manner and continued to operate with vigour to drive local expertiseand truly live up to its title as the 'Pharmacy of the World', he added.

"Having said that, providing impetus to domestic manufacturers willstrengthen the industrygoing forward.This will usher a new era for the country's healthcare and pharma sector," Jain said.

The government had earlier come out with greater contours ofactive pharmaceuticalingredient (API)policy which is expected to increase self-reliance in fermentation-based API industry, he added.

"IPA is committed toproviding quality medicines to thepatients in need and we applaudHon'ble PM's vision fora self-reliant India, Jain said.

In similar vein, the Indian Drug Manufacturers' Association (IDMA) also praised Modi's speech on emphasis on self-reliance.

"The PM has very rightly mentioned in his address to nation that it was only the 'local' which came to our help during these unprecedented times," IDMAExecutive Director Ashok Kumar Madan said.

Whether HCQor any other formulation, India's uninhibited exports to all nations and its neighbours have again proved India's image as 'Pharmacy of the World', he added.

"IDMA with its membership of large, medium and small enterprises across the country,reassures the nation of pharma industries' commitment to serve the nation and the humanity," Madan said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 13 2020 | 4:25 PM IST

Next Story